doi:10.1093/jn/134.3.489 Semenova NV, Madaeva IM, Brichagina AS, Kolesnikov SI, Kolesnikova LI
Researchers believe GIP co-activation may have a protective effect on the GI tract, explaining why dual and triple agonists are often better tolerated than single-agonist Semaglutide (which has 44% nausea rates)
Semaglutide: definition and mechanism of action Currently, one of the most effective medications used for the treatment of obesity in patients is semaglutide (trade names: Ozempic, Wegovy, and Rybelsus)
Patients should disclose all current medications, including prescription drugs, over-the-counter medicines, herbal products, vitamins, and nutritional supplements
Oral Tirzepatide formulations are in late-stage trials